323 related articles for article (PubMed ID: 25447851)
21. Obesity and risk of esophageal adenocarcinoma and Barrett's esophagus: a Mendelian randomization study.
Thrift AP; Shaheen NJ; Gammon MD; Bernstein L; Reid BJ; Onstad L; Risch HA; Liu G; Bird NC; Wu AH; Corley DA; Romero Y; Chanock SJ; Chow WH; Casson AG; Levine DM; Zhang R; Ek WE; MacGregor S; Ye W; Hardie LJ; Vaughan TL; Whiteman DC
J Natl Cancer Inst; 2014 Nov; 106(11):. PubMed ID: 25269698
[TBL] [Abstract][Full Text] [Related]
22. A population-based association study of SNPs of GSTP1, MnSOD, GPX2 and Barrett's esophagus and esophageal adenocarcinoma.
Murphy SJ; Hughes AE; Patterson CC; Anderson LA; Watson RG; Johnston BT; Comber H; McGuigan J; Reynolds JV; Murray LJ
Carcinogenesis; 2007 Jun; 28(6):1323-8. PubMed ID: 17277236
[TBL] [Abstract][Full Text] [Related]
23. Sex-Specific Genetic Associations for Barrett's Esophagus and Esophageal Adenocarcinoma.
Dong J; Maj C; Tsavachidis S; Ostrom QT; Gharahkhani P; Anderson LA; Wu AH; Ye W; Bernstein L; Borisov O; Schröder J; Chow WH; Gammon MD; Liu G; Caldas C; Pharoah PD; Risch HA; May A; Gerges C; Anders M; Venerito M; Schmidt T; Izbicki JR; Hölscher AH; Schumacher B; Vashist Y; Neuhaus H; Rösch T; Knapp M; Krawitz P; Böhmer A; Iyer PG; Reid BJ; Lagergren J; Shaheen NJ; Corley DA; Gockel I; Fitzgerald RC; ; Cook MB; Whiteman DC; Vaughan TL; Schumacher J; Thrift AP
Gastroenterology; 2020 Dec; 159(6):2065-2076.e1. PubMed ID: 32918910
[TBL] [Abstract][Full Text] [Related]
24. Phase I and II enzyme polymorphisms as risk factors for Barrett's esophagus and esophageal adenocarcinoma: a systematic review and meta-analysis.
Bull LM; White DL; Bray M; Nurgalieva Z; El-Serag HB
Dis Esophagus; 2009; 22(7):571-87. PubMed ID: 19222528
[TBL] [Abstract][Full Text] [Related]
25. No association between hOGG1, XRCC1, and XPD polymorphisms and risk of reflux esophagitis, Barrett's esophagus, or esophageal adenocarcinoma: results from the factors influencing the Barrett's adenocarcinoma relationship case-control study.
Ferguson HR; Wild CP; Anderson LA; Murphy SJ; Johnston BT; Murray LJ; Watson RG; McGuigan J; Reynolds JV; Hardie LJ
Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):736-9. PubMed ID: 18349297
[TBL] [Abstract][Full Text] [Related]
26. Genetic variants in Barrett's esophagus and esophageal adenocarcinoma: a literature review.
Callahan ZM; Shi Z; Su B; Xu J; Ujiki M
Dis Esophagus; 2019 Aug; 32(8):. PubMed ID: 30888413
[TBL] [Abstract][Full Text] [Related]
27. Cyclooxygenase-2 and inducible nitric oxide synthase gene polymorphisms and risk of reflux esophagitis, Barrett's esophagus, and esophageal adenocarcinoma.
Ferguson HR; Wild CP; Anderson LA; Murphy SJ; Johnston BT; Murray LJ; Watson RG; McGuigan J; Reynolds JV; Hardie LJ
Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):727-31. PubMed ID: 18349295
[TBL] [Abstract][Full Text] [Related]
28. Germline variant in MSX1 identified in a Dutch family with clustering of Barrett's esophagus and esophageal adenocarcinoma.
van Nistelrooij AMJ; van Marion R; van Ijcken WFJ; de Klein A; Wagner A; Biermann K; Spaander MCW; van Lanschot JJB; Dinjens WNM; Wijnhoven BPL
Fam Cancer; 2018 Jul; 17(3):435-440. PubMed ID: 29134539
[TBL] [Abstract][Full Text] [Related]
29. Germline variation in inflammation-related pathways and risk of Barrett's oesophagus and oesophageal adenocarcinoma.
Buas MF; He Q; Johnson LG; Onstad L; Levine DM; Thrift AP; Gharahkhani P; Palles C; Lagergren J; Fitzgerald RC; Ye W; Caldas C; Bird NC; Shaheen NJ; Bernstein L; Gammon MD; Wu AH; Hardie LJ; Pharoah PD; Liu G; Iyer P; Corley DA; Risch HA; Chow WH; Prenen H; Chegwidden L; Love S; Attwood S; Moayyedi P; MacDonald D; Harrison R; Watson P; Barr H; deCaestecker J; Tomlinson I; Jankowski J; Whiteman DC; MacGregor S; Vaughan TL; Madeleine MM
Gut; 2017 Oct; 66(10):1739-1747. PubMed ID: 27486097
[TBL] [Abstract][Full Text] [Related]
30. An esophageal adenocarcinoma susceptibility locus at 9q22 also confers risk to esophageal squamous cell carcinoma by regulating the function of BARX1.
Yan C; Ji Y; Huang T; Yu F; Gao Y; Gu Y; Qi Q; Du J; Dai J; Ma H; Jin G
Cancer Lett; 2018 May; 421():103-111. PubMed ID: 29454095
[TBL] [Abstract][Full Text] [Related]
31. Whole-genome sequencing provides new insights into the clonal architecture of Barrett's esophagus and esophageal adenocarcinoma.
Ross-Innes CS; Becq J; Warren A; Cheetham RK; Northen H; O'Donovan M; Malhotra S; di Pietro M; Ivakhno S; He M; Weaver JMJ; Lynch AG; Kingsbury Z; Ross M; Humphray S; Bentley D; Fitzgerald RC
Nat Genet; 2015 Sep; 47(9):1038-1046. PubMed ID: 26192915
[TBL] [Abstract][Full Text] [Related]
32. Genome-wide catalogue of chromosomal aberrations in barrett's esophagus and esophageal adenocarcinoma: a high-density single nucleotide polymorphism array analysis.
Gu J; Ajani JA; Hawk ET; Ye Y; Lee JH; Bhutani MS; Hofstetter WL; Swisher SG; Wang KK; Wu X
Cancer Prev Res (Phila); 2010 Sep; 3(9):1176-86. PubMed ID: 20651033
[TBL] [Abstract][Full Text] [Related]
33. Genomic regions associated with susceptibility to Barrett's esophagus and esophageal adenocarcinoma in African Americans: The cross BETRNet admixture study.
Sun X; Chandar AK; Canto MI; Thota PN; Brock M; Shaheen NJ; Beer DG; Wang JS; Falk GW; Iyer PG; Abrams JA; Venkat-Ramani M; Veigl M; Miron A; Willis J; Patil DT; Nalbantoglu I; Guda K; Markowitz SD; Zhu X; Elston R; Chak A
PLoS One; 2017; 12(10):e0184962. PubMed ID: 29073141
[TBL] [Abstract][Full Text] [Related]
34. Constrained Score Statistics Identify Genetic Variants Interacting with Multiple Risk Factors in Barrett's Esophagus.
Dai JY; Tapsoba Jde D; Buas MF; ; Risch HA; Vaughan TL
Am J Hum Genet; 2016 Aug; 99(2):352-65. PubMed ID: 27486777
[TBL] [Abstract][Full Text] [Related]
35. Association of methylenetetrahydrofolate reductase C677T-A1298C polymorphisms with risk for esophageal adenocarcinoma, Barrett's esophagus, and reflux esophagitis.
Ekiz F; Ormeci N; Coban S; Karabulut HG; Aktas B; Tukun A; Tuncali T; Yüksel O; Alkış N
Dis Esophagus; 2012 Jul; 25(5):437-41. PubMed ID: 21951971
[TBL] [Abstract][Full Text] [Related]
36. Gains and amplifications of c-myc, EGFR, and 20.q13 loci in the no dysplasia-dysplasia-adenocarcinoma sequence of Barrett's esophagus.
Rygiel AM; Milano F; Ten Kate FJ; Schaap A; Wang KK; Peppelenbosch MP; Bergman JJ; Krishnadath KK
Cancer Epidemiol Biomarkers Prev; 2008 Jun; 17(6):1380-5. PubMed ID: 18559552
[TBL] [Abstract][Full Text] [Related]
37. Global DNA methylation patterns in Barrett's esophagus, dysplastic Barrett's, and esophageal adenocarcinoma are associated with BMI, gender, and tobacco use.
Kaz AM; Wong CJ; Varadan V; Willis JE; Chak A; Grady WM
Clin Epigenetics; 2016; 8():111. PubMed ID: 27795744
[TBL] [Abstract][Full Text] [Related]
38. eQTL Set-Based Association Analysis Identifies Novel Susceptibility Loci for Barrett Esophagus and Esophageal Adenocarcinoma.
Wang X; Gharahkhani P; Levine DM; Fitzgerald RC; Gockel I; Corley DA; Risch HA; Bernstein L; Chow WH; Onstad L; Shaheen NJ; Lagergren J; Hardie LJ; Wu AH; Pharoah PDP; Liu G; Anderson LA; Iyer PG; Gammon MD; Caldas C; Ye W; Barr H; Moayyedi P; Harrison R; Watson RGP; Attwood S; Chegwidden L; Love SB; MacDonald D; deCaestecker J; Prenen H; Ott K; Moebus S; Venerito M; Lang H; Mayershofer R; Knapp M; Veits L; Gerges C; Weismüller J; Reeh M; Nöthen MM; Izbicki JR; Manner H; Neuhaus H; Rösch T; Böhmer AC; Hölscher AH; Anders M; Pech O; Schumacher B; Schmidt C; Schmidt T; Noder T; Lorenz D; Vieth M; May A; Hess T; Kreuser N; Becker J; Ell C; Tomlinson I; Palles C; Jankowski JA; Whiteman DC; MacGregor S; Schumacher J; Vaughan TL; Buas MF; Dai JY
Cancer Epidemiol Biomarkers Prev; 2022 Sep; 31(9):1735-1745. PubMed ID: 35709760
[TBL] [Abstract][Full Text] [Related]
39. Chromosomal abnormalities and novel disease-related regions in progression from Barrett's esophagus to esophageal adenocarcinoma.
Akagi T; Ito T; Kato M; Jin Z; Cheng Y; Kan T; Yamamoto G; Olaru A; Kawamata N; Boult J; Soukiasian HJ; Miller CW; Ogawa S; Meltzer SJ; Koeffler HP
Int J Cancer; 2009 Nov; 125(10):2349-59. PubMed ID: 19670330
[TBL] [Abstract][Full Text] [Related]
40. Progression of Barrett's metaplasia to adenocarcinoma is associated with the suppression of the transcriptional programs of epidermal differentiation.
Kimchi ET; Posner MC; Park JO; Darga TE; Kocherginsky M; Karrison T; Hart J; Smith KD; Mezhir JJ; Weichselbaum RR; Khodarev NN
Cancer Res; 2005 Apr; 65(8):3146-54. PubMed ID: 15833844
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
